| Genmab A/S | 2,660.00 / +2.03% |
| Date/Time | 08/19 / 16:54 |
| Chg. / Chg.(%) | 53.00 / +2.03% |
| Bid | - |
| Ask | - |
| Open | 2,611.00 |
| Previous Close | 2,607.00 |
| High | 2,669.00 |
| Low | 2,611.00 |
| Volume [DKK] | 37,066,198.50 |
| Volume [Units] | 32,621 |
| Price fixings | 2372 |
| ISIN | DK0010272202 |
| Security | GMAB/C |
| Exchange | Cboe Europe DXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| OMX Nordic | 2,669.00 |  |
100,164 |
| Cboe Europe .. | 2,660.00 | |
32,621 |
| London Inter.. | 2,656.0 | |
9,847 |
| Turquoise | 2,659.00 | |
4,868 |
| Nasdaq Other.. | 356.1000 |  |
294 |
| TradeGate | 356.700 | |
59 |
| Cboe Europe .. | 2,652.50 | |
41 |
| Frankfurt | 358.5000 | |
4 |
| Vienna Globa.. | 358.50 | |
0 |
| München | 353.20 | |
0 |
| Düsseldorf | 357.60 | |
0 |
| Hannover | 353.10 | |
0 |
| Berlin | 358.00 | |
0 |
| Stuttgart | 355.300 | |
0 |
| Quotrix | 354.0000 | |
|
| Lang & Schwa.. | 356.60 | |
|
| gettex | 357.000 | |
|
| Cboe Europe .. | 2,668.00 | 2 |
News
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
03/15/2022 / 23:00 - GlobeNewswire - BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
03/08/2022 / 14:27 - GlobeNewswire - Notice to Convene the Annual General Meeting of Genmab A/S
02/24/2022 / 12:01 - GlobeNewswire - PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
02/21/2022 / 19:25 - pressetext - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire
Real-time